157 related articles for article (PubMed ID: 2067442)
1. Neuroleptic malignant syndrome complicating levodopa withdrawal.
Reutens DC; Harrison WB; Goldswain PR
Med J Aust; 1991 Jul; 155(1):53-4. PubMed ID: 2067442
[TBL] [Abstract][Full Text] [Related]
2. Levodopa withdrawal syndrome identical to neuroleptic malignant syndrome.
Gibb WR; Griffith DN
Postgrad Med J; 1986 Jan; 62(723):59-60. PubMed ID: 3797365
[TBL] [Abstract][Full Text] [Related]
3. [Successful treatment of levodopa-induced neuroleptic malignant syndrome (NMS) with disseminated intravascular coagulation (DIC) in a patient with Parkinson's disease].
Yamawaki Y; Ogawa N
Rinsho Shinkeigaku; 1991 Jan; 31(1):62-7. PubMed ID: 2044308
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment of levodopa-induced neuroleptic malignant syndrome (NMS) and disseminated intravascular coagulation (DIC) in a patient with Parkinson's disease.
Yamawaki Y; Ogawa N
Intern Med; 1992 Nov; 31(11):1298-302. PubMed ID: 1295627
[TBL] [Abstract][Full Text] [Related]
5. [Malignant syndrome associated with disseminated intravascular coagulation and a high level of amylase in serum, followed by diabetic coma in an elderly patient with Parkinson's disease during L-dopa therapy].
Saeki H; Muneta S; Kobayashi T
Nihon Ronen Igakkai Zasshi; 1998 Feb; 35(2):139-44. PubMed ID: 9584493
[TBL] [Abstract][Full Text] [Related]
6. [Case of neuroleptic malignant syndrome following open heart surgery for thoracic aortic aneurysm with parkinson's disease].
Shinoda M; Sakamoto M; Shindo Y; Ando Y; Tateda T
Masui; 2013 Dec; 62(12):1453-6. PubMed ID: 24498782
[TBL] [Abstract][Full Text] [Related]
7. Neuroleptic malignant syndrome in striatonigral degeneration.
Gibb WR
Br J Psychiatry; 1988 Aug; 153():254-5. PubMed ID: 3255444
[TBL] [Abstract][Full Text] [Related]
8. Neuroleptic malignant syndrome in a patient with Parkinson's disease: a case study.
Ward C
J Neurosci Nurs; 2005 Jun; 37(3):160-2. PubMed ID: 16001822
[TBL] [Abstract][Full Text] [Related]
9. Neuroleptic malignant syndrome. When levodopa withdrawal is the cause.
Rainer C; Scheinost NA; Lefeber EJ
Postgrad Med; 1991 Apr; 89(5):175-8, 180. PubMed ID: 2008397
[TBL] [Abstract][Full Text] [Related]
10. Malignant syndrome in Parkinson's disease: concept and review of the literature.
Mizuno Y; Takubo H; Mizuta E; Kuno S
Parkinsonism Relat Disord; 2003 Apr; 9 Suppl 1():S3-9. PubMed ID: 12735909
[TBL] [Abstract][Full Text] [Related]
11. Neuroleptic malignant syndrome in advanced Parkinson's disease.
Gordon PH; Frucht SJ
Mov Disord; 2001 Sep; 16(5):960-2. PubMed ID: 11746631
[TBL] [Abstract][Full Text] [Related]
12. Case of neuroleptic malignant-like syndrome precipitated by abrupt fava bean discontinuance.
Ladha SS; Walker R; Shill HA
Mov Disord; 2005 May; 20(5):630-1. PubMed ID: 15719433
[TBL] [Abstract][Full Text] [Related]
13. Neuroleptic malignant syndrome in Parkinson's disease after withdrawal or alteration of dopaminergic therapy.
Keyser DL; Rodnitzky RL
Arch Intern Med; 1991 Apr; 151(4):794-6. PubMed ID: 1672810
[TBL] [Abstract][Full Text] [Related]
14. A neuroleptic malignantlike syndrome due to levodopa therapy withdrawal.
Friedman JH; Feinberg SS; Feldman RG
JAMA; 1985 Nov; 254(19):2792-5. PubMed ID: 4057489
[TBL] [Abstract][Full Text] [Related]
15. Neuroleptic malignant syndrome without neuroleptics.
Ong KC; Chew EL; Ong YY
Singapore Med J; 2001 Feb; 42(2):85-8. PubMed ID: 11358199
[TBL] [Abstract][Full Text] [Related]
16. Neuroleptic malignant syndrome-like, or--dopaminergic malignant syndrome--due to levodopa therapy withdrawal. Clinical features in 11 patients.
Serrano-Dueñas M
Parkinsonism Relat Disord; 2003 Jan; 9(3):175-8. PubMed ID: 12573874
[TBL] [Abstract][Full Text] [Related]
17. Successful treatment of levodopa-induced myoclonus and levodopa withdrawal-induced neuroleptic malignant syndrome. A case report.
Hirschorn KA; Greenberg HS
Clin Neuropharmacol; 1988 Jun; 11(3):278-81. PubMed ID: 3401861
[No Abstract] [Full Text] [Related]
18. Apomorphine in malignant syndrome due to levodopa withdrawal.
Bonuccelli U; Piccini P; Corsini GU; Muratorio A
Ital J Neurol Sci; 1992 Mar; 13(2):169-70. PubMed ID: 1592579
[TBL] [Abstract][Full Text] [Related]
19. Neuroleptic malignant-like syndrome causing thrombocytopaenia: a rare association.
Sahu H; Manjunath MB; Ray A; Vikram NK
BMJ Case Rep; 2018 Dec; 11(1):. PubMed ID: 30567175
[TBL] [Abstract][Full Text] [Related]
20. A neuroleptic malignant-like syndrome (NMLS) in a patient with Parkinson's disease resolved with rotigotine: a case report.
Fiore S; Persichino L; Anticoli S; De Pandis MF
Acta Biomed; 2014 Dec; 85(3):281-4. PubMed ID: 25567468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
